The specific disease burden of neuropathic pain: Results of a French nationwide survey

Pain ◽  
2011 ◽  
Vol 152 (12) ◽  
pp. 2836-2843 ◽  
Author(s):  
Nadine Attal ◽  
Michel Lanteri-Minet ◽  
Bernard Laurent ◽  
Jacques Fermanian ◽  
Didier Bouhassira
PLoS ONE ◽  
2014 ◽  
Vol 9 (3) ◽  
pp. e90203 ◽  
Author(s):  
Jaroslav Flegr ◽  
Joseph Prandota ◽  
Michaela Sovičková ◽  
Zafar H. Israili

2021 ◽  
Vol 14 (1) ◽  
pp. e240863
Author(s):  
Lisa Killion ◽  
Paula Evelyn Beatty ◽  
Asad Salim

The COVID-19 pandemic has resulted in an incomparable disease burden worldwide. One of the main contributors stems from the multisystem inflammatory syndrome associated with SARS-CoV-2 infection. The numbers of those affected continue to rise with the increasing number of confirmed COVID-19 cases. However, we are yet to fully comprehend the risk factors, disease progression and prognosis for individuals affected. We describe a case of a previously healthy 17-year-old boy who tested positive for the SARS-CoV-2 virus. He presented with a 5-day history of mild influenza-like symptoms, however, quickly required ventilatory support in the intensive care unit. Two months postdischarge, he developed an isolated petechial rash on his palms and soles. His cutaneous presentation was in association with a mixed sensorimotor peripheral neuropathy, debilitating neuropathic pain and intermittent respiratory distress. We postulate that cutaneous manifestations post-COVID-19 could be indicatory of the newly identified multisystem inflammatory syndrome.


2014 ◽  
Vol 17 (7) ◽  
pp. A535-A536
Author(s):  
Y.E. Cho ◽  
S.H. Moon ◽  
C.J. Whang ◽  
H.J. Kim

2016 ◽  
Vol 46 (3) ◽  
pp. 166-172 ◽  
Author(s):  
Cristina Marcoci ◽  
Vitalie Lisnic ◽  
Mihail Gavriliuc ◽  
Olesea Odainic ◽  
Marina Sangheli ◽  
...  

Background: The occurrence of multiple sclerosis (MS) increases in populations featuring both high and low disease burden, and variations across regions at the same latitude are reported. MS epidemiological data in Eastern Europe are scarce and out of date. We report on sex- and age-specific prevalence of MS in the Republic of Moldova. Methods: Benefitting from a nationwide survey aimed to quantify the MS burden in Moldovans (3,559,541 population in 2012), multiple epidemiological sources were scrutinized. Results: On prevalence day, December 31, 2012, 747 MS patients (McDonald criteria) resided in the study area, yielding a crude prevalence of 20.9 per 100,000 (95% CI 14.7-27.1), 25.7 (95% CI 20.5-30.5) in women and 15.8 (95% CI 12.2-19.3) in men (F:M ratio of 1.63), and standardized estimates of 20.2, 24.3 and 15.5 per 100,000, respectively. Prevalence was highest in the age group 40-49 years (43.9 per 100,000) and higher in rural (72.6%) than in urban (27.4%) areas. Conclusions: This is the first report on sex- and age-specific prevalence of MS in the Republic of Moldova, which was lower than in Europe on average, but consistent with that of neighboring countries, Romania and Ukraine. Moldovans represent a population wherein MS natural history is not yet influenced by use of disease-modifying drugs.


2018 ◽  
Vol 24 (6) ◽  
pp. 324-327 ◽  
Author(s):  
Kevser Gok ◽  
Gizem Cengiz ◽  
Kemal Erol ◽  
Salih Ozgocmen

2005 ◽  
Vol 38 (10) ◽  
pp. 15
Author(s):  
Sherry Boschert
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document